20.12.2012 Views

FR AB - Science Reference

FR AB - Science Reference

FR AB - Science Reference

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Implementation of Automation<br />

in a Small-Scale DNA<br />

Sequencing Core Facility<br />

Jennifer L. Ware, Laurie Moran,<br />

Ching-Lun Lin, and Barton Slatko<br />

New England Biolabs, Inc., Beverly, MA<br />

METHODS<br />

REVIEWS<br />

New England Biolabs (NEB) sequencing core facility provides<br />

automated sequencing services to support various<br />

company-wide projects in house, but on a very small scale of<br />

about 1000 to1500 reactions per month. A procedure has<br />

been implemented at the NEB core sequencing facility to<br />

integrate simplified methods and robotics to provide a more<br />

efficient small-scale process. This has been done using a<br />

Beckman Biomek 2000 robot combined with an MJ DNA<br />

Engine, 96-well plate cycler (PTC-200), <strong>AB</strong> 373 and 377<br />

sequencers, BMA Singel gels, and several other materials that<br />

help reduce the time required for otherwise lengthy procedures<br />

in a cost-efficient manner. Protocols have also been<br />

developed for efficient sequencing of a variety of templates<br />

submitted to the NEB core facility. (J Biomol Tech 2000;11:<br />

151–154)<br />

KEY WORDS: automation, robotics, sequencing template<br />

cleanup, small-scale DNA sequencing.<br />

ADDRESS CORRESPONDENCE AND REPRINT REQUESTS TO: Jennifer L.<br />

Ware, New England Biolabs, Inc., 32 Tozer Road, Beverly, MA<br />

01915 (email: ware@neb.com).<br />

&<br />

Journal of Biomolecular Techniques<br />

11:151–154 © 2000 <strong>AB</strong>RF<br />

RF <strong>AB</strong><br />

Genome sequencing and analysis technology<br />

has advanced in a manner that allows companies<br />

to generate enormous amounts of data<br />

per day, via automated processes, in an effort to complete<br />

genome projects and use that information as a<br />

source of possible disease treatment and control.<br />

Unfortunately, smaller core facilities, which have less<br />

of a need to produce such high-throughput data, are<br />

not the primary targets of application of these<br />

advanced technologies and are in need of simplified<br />

methods. The core sequencing laboratory at New<br />

England Biolabs, Inc. (NEB, Beverly, MA) has combined<br />

recent advances in sequencing technology to<br />

efficiently simplify the process from beginning to end.<br />

The sequencing core facility provides additional measures<br />

of quality control of appropriate DNA products<br />

for sale at NEB, such as sequencing primers and other<br />

oligonucleotides, cloning vectors by sequencing reaction<br />

assay, and vector and phage display products to<br />

ensure correct sequence. For our in-house research<br />

program, sequences are required from vector and<br />

overexpression constructs of clones, cDNA, polymerase<br />

chain reaction (PCR), phage display, and other<br />

sequencing templates, including our involvement in<br />

the Filarial Genome Project (http://www.neb.com/<br />

fgn/filgen1.html). Among those templates submitted<br />

for analysis are plasmids, M13 derivatives, � phage,<br />

PCR products, cosmids, and bacterial artificial chromosomes<br />

(BACs), each of which requires a different<br />

amount of template and/or primer per reaction and<br />

sometimes different sequencing reaction conditions as<br />

well.<br />

ELECTRONIC SUBMISSION<br />

To make this process efficient from beginning to end,<br />

researchers start by submitting an electronic form to<br />

the core facility in which key information necessary to<br />

perform the sequencing is provided. The form is accessible<br />

on the DNA Sequencing Core Facility intranet<br />

JOURNAL OF BIOMOLECULAR TECHNIQUES, VOLUME 11, ISSUE 4, DECEMBER 2000 151

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!